ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$19.41M	-
Other	Edwards Larry Todd	150.2K	$3.94M	-
Other	Matsuda Masaru	127.6K	$3.34M	-
Other	Burnett Patrick	120.2K	$3.15M	-
CFO	Vairavan Latha	86.0K	$2.25M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 1, 2025	Matsuda Masaru51	See Remarks	Sell	1,657	$30.23	$50,091.11	-1.1%	-18.5%	-
Dec 1, 2025	Welgus Howard G.61	Director	Sell	10,000	$30.21	$302,133.00	-11.1%	-18.5%	-
Nov 24, 2025	Lin Sue-Jean	Director	Sale+OE	25,272	$30.78	$777,955.56	-48.6%	-14.5%	-
Nov 24, 2025	Watanabe Todd65	See Remarks	Sell	50,000	$30.35	$1,517,404.84	-3.2%	-14.5%	-
Nov 20, 2025	Gilbert Halley E	Director	Sale+OE	16,532	$27.55	$455,441.72	-42.8%	-2.3%	-
Nov 19, 2025	Matsuda Masaru51	See Remarks	Sell	2,550	$28.29	$72,135.10	-0.8%	-4.6%	-
Nov 13, 2025	Krishnamohan Neha	Director	Sale+OE	40,504	$23.20	$939,493.81	-47.1%	+16.3%	-
Nov 6, 2025	Edwards Larry Todd	See Remarks	Sell	29,131	$25.16	$732,927.22	-16.2%	+3.9%	-
Nov 6, 2025	Burnett Patrick	See Remarks	Sale+OE	17,250	$24.18	$417,144.68	-14.9%	+3.9%	-
Nov 5, 2025	Burnett Patrick	See Remarks	Sell	6,486	$24.12	$156,449.49	-2.1%	+7.4%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC